Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2012
06/19/2012CA2534565C Reconstitution medium for protein and peptide formulations
06/19/2012CA2523844C Stable thrombin composition
06/19/2012CA2473694C Use of calmodulin to promote bone regeneration
06/19/2012CA2469939C Method of inducing ovulation using a non-polypeptide camp level modulator
06/19/2012CA2422538C Notch receptor agonists and uses
06/19/2012CA2406169C Polyamide nucleic acid derivatives, and agents and processes for preparing them
06/19/2012CA2400534C A dominant selectable marker for gene transformation and disruption in yeasts
06/19/2012CA2393975C Insect poison allergens with reduced ige reactivity and method for producing the same
06/19/2012CA2390898C Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
06/19/2012CA2314610C Method for preparing by filtration a virally secure factor viii solution
06/19/2012CA2312976C Compositions comprising histidine-linked protein polymer conjugates
06/19/2012CA2311166C Nucleic acids involved in the responder phenotype and applications thereof
06/14/2012WO2012079088A2 Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases
06/14/2012WO2012078982A2 Xzh-5 inhibits constitutive and interleukin-6-induced stat3 phosphorylation in human hepatocellular carcinoma cells
06/14/2012WO2012078736A2 Fibrinogen and kidney damage
06/14/2012WO2012078734A2 Polypeptide derived from calcitonin receptors and methods of use
06/14/2012WO2012078101A1 Method for the treatment of il-1 mediated diseases
06/14/2012WO2012077131A1 A stable ready-to-use cetrorelix injection
06/14/2012WO2012077076A1 Treating or preventing sensitivity to milk allergens
06/14/2012WO2012077024A1 Composition for inhibiting the growth of mammalian hair
06/14/2012WO2012076708A1 Immune restricted peptides with increased efficacy
06/14/2012WO2012076694A1 Cancer gene therapy using nucleic acids encoding us28 and g-protein
06/14/2012WO2012076555A1 Autophagy enhancing compounds, peptides and peptidomimetic compounds for use in the treatment of neuronal diseases
06/14/2012WO2012076322A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/14/2012WO2012076194A1 Combination preparations comprising a cytokine antagonist and corticosteroid
06/14/2012WO2012076193A1 Combination preparations comprising exosomes and corticosteroid
06/14/2012WO2012076059A1 Immune restricted peptides with increased efficacy
06/14/2012WO2012075911A1 Use of recombinant human prx-6 protein in treatment of burn and scald and/or corneal injury
06/14/2012WO2012075679A1 Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer
06/14/2012WO2012075570A1 Bioactive peptides and proteins containing bioactive peptides, their uses and processes for making the same
06/14/2012WO2012075549A2 Agents for increased resistance against oxidative stress conditions
06/14/2012WO2012058625A3 Assays and kits to determine galactocerebrosidase activity on solid support
06/14/2012WO2012054816A3 Methods of delaying and treating diabetes
06/14/2012WO2012052629A3 Cyclin-a2 as a tumorigenesis biomarker and uses for obtaining anti-metastatic compounds
06/14/2012WO2012050930A3 Engineered polypeptides having enhanced duration of action
06/14/2012WO2012050714A3 Cartilage oligomeric matrix protein (comp)-growth factor complexes and uses thereof
06/14/2012WO2012050303A3 Pharmaceutical composition for cancer prevention and treatment containing the c12orf59 gene or protein as an active ingredient
06/14/2012WO2012049307A3 Novel n-terminally modified insulin derivatives
06/14/2012WO2012047930A3 Compositions and methods for treatment of gynecologic cancers
06/14/2012WO2012044939A3 Method of preparing a dry powder from a water bacteria extract-concentrate
06/14/2012WO2012040459A3 Beta-catenin targeting peptides and uses thereof
06/14/2012WO2012031296A3 Methods and composition for inhibiting or attenuating leukocyte-endothelial interactions
06/14/2012WO2012027379A3 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
06/14/2012WO2012021891A3 Compositions, kits and methods for treatment of complement-related disorders
06/14/2012WO2011163531A3 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases
06/14/2012WO2011153235A3 Compositions featuring superoxide dismutase polypeptides having enhanced anti-oxidant activity
06/14/2012WO2011149310A9 Peptide for inhibiting interaction between rankl and rank, and pharmaceutical composition containing same
06/14/2012WO2011140135A9 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
06/14/2012WO2011134979A3 Stable aqueous mia/cd-rap formulations
06/14/2012WO2011088462A3 Alpha-fetoprotein 'ring and tail' peptides
06/14/2012WO2011008939A3 Porous-wall hollow glass microspheres as carriers for biomolecules
06/14/2012US20120150087 Solid dressing for treating wounded tissue
06/14/2012US20120149890 Polynucleotides Encoding Thymidine Kinase Mutants
06/14/2012US20120149869 Alpha-conotoxin peptides
06/14/2012US20120149755 Antisense oligonucleotide modulation of raf gene expression
06/14/2012US20120149653 Multifunctional linkers and methods for the use thereof
06/14/2012US20120149652 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
06/14/2012US20120149651 Caveolin peptides and their use as therapeutics
06/14/2012US20120149650 Diphtheria Toxin Variant
06/14/2012US20120149649 Short-chain cationic polyamino acid and use thereof
06/14/2012US20120149648 Therapeutic peptidomimetic macrocycles
06/14/2012US20120149647 Methods for Assessing the Efficacy of Gemcitabine or Ara-C Treatment of Cancer Using Human Antigen R Levels
06/14/2012US20120149646 Long term potentiation with cyclic-glur6 analogs
06/14/2012US20120149645 Compositions and modulation of myocyte enhancer factor 2 (mef2)
06/14/2012US20120149644 Compositions and methods for treating growth hormone deficiency
06/14/2012US20120149643 Safe Desmopressin Administration
06/14/2012US20120149642 Fibrosis inhibitor for implanted organ
06/14/2012US20120149641 Methods and Compositions for Regenerating Articular Cartilage
06/14/2012US20120149640 Peptides modulating the activity of igf-1 and the applications of said peptides
06/14/2012US20120149639 Use of a dpp-iv inhibitor to reduce hypoglycemic events
06/14/2012US20120149638 Methods for preventing or treating insulin resistance
06/14/2012US20120149637 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/14/2012US20120149636 Modified Leptin Polypeptides and Their Uses
06/14/2012US20120149635 Treatment for obesity
06/14/2012US20120149634 Compounds and methods for treating bone disorders and controlling weight
06/14/2012US20120149633 Modulation of cd4+ t cell responses by a tick saliva protein, salp15 and polypeptides derived therefrom
06/14/2012US20120149632 Glycopeptide and lipoglycopeptide antibiotics with improved solubility
06/14/2012US20120149630 End-modified poly(beta-amino esters) and uses thereof
06/14/2012US20120149102 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
06/14/2012US20120149084 Fusion proteins
06/14/2012US20120149083 PEG-Urate Oxidase Conjugates and Use Thereof
06/14/2012US20120149062 High Purity Lipopeptides
06/14/2012US20120148688 Prevention of thrombus formation and/or stabilization
06/14/2012US20120148684 Methods useful in the treatment of bone resorption diseases
06/14/2012US20120148681 Peptides and peptide compositions having osteoinductive activity
06/14/2012US20120148677 Controlled release particles containing acid fibroblast growth factor
06/14/2012US20120148676 Artificial cell constructs for cellular manipulation
06/14/2012US20120148674 Self-assembling hydrogels based on dicephalic peptide amphiphiles
06/14/2012US20120148673 Peptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1
06/14/2012US20120148670 Sensitive polymer capsule and method of manufacturing the same
06/14/2012US20120148660 Conjugates of synthetic tlr agonists and uses therefor
06/14/2012US20120148659 Solid dressing for treating wounded tissue
06/14/2012US20120148658 Solid dressing for treating wounded tissue
06/14/2012US20120148657 Lipoxygenase and Its Use in Wound Healing
06/14/2012US20120148656 Sheet-form preparation and method for producing the same
06/14/2012US20120148654 Method and system for a photoresist-based immunoisolative microcontainer with nanoslots defined by nanoimprint lithography
06/14/2012US20120148642 Multi-domain amphipathic helical peptides and methods of their use
06/14/2012US20120148628 Compositions and methods for treatment of cancer
06/14/2012US20120148616 Neisseria meningitidis antigens and compositions
06/14/2012US20120148610 Monomethylvaline compounds capable of conjugation to ligands
1 ... 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 ... 3163